Rendered visual concept — not inventory photography. Label text in imagery is decorative.
Skin & Cosmetic
GHK-Cu 100 mg
Copper(II) glycyl-L-histidyl-L-lysine tripeptide
Strength
100 mg
Vial count
Unspecified
Strength of evidence
Early human studies
Research summary
Copper-binding tripeptide studied mainly in topical cosmetic formulations and in vitro skin models. The 100 mg designation identifies the supplied catalogue size, not a dosing recommendation.
Regulatory status
Cosmetic topical use is regulated separately; injectable forms are not approved. This informational entry does not establish authorization for consumer sale in Canada.
No certificate of analysis or purity figure is shown because none has been verified for this demo. No dosing information is provided.
Information only. Purchases and payments are disabled.
Regulatory notice (Canada): Labelling a product “for research use only” does not make it legal to sell unapproved injectable peptides. In Canada, drugs for human use require Health Canada authorization. This site is a non-transactional design demo: nothing is for sale, and nothing here is medical advice or dosing guidance.
